Short answer: Arginine and citrulline interventions for hypertension — Pharmaceuticals, 2024 is a specific, named journal citation worth checking directly rather than taking the summary at face value.
Why naming the specific journal and year matters
Rather than a vague "studies show" claim, naming Pharmaceuticals and the 2024 publication date directly gives you something concrete to verify yourself.
Why the site directly clarifies what this citation does and doesn't prove
These citations refer to research on the individual amino acids, not the finished BloodPril product, which has not been the subject of its own clinical trial.
💡 Worth knowing: this same distinction between ingredient research and finished-product evidence is worth applying to any of the five cited sources listed on the page.